Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001922964-26-000006
Filing Date
2026-03-16
Accepted
2026-03-16 17:06:03
Documents
1
Period of Report
2026-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1773695160.html 4  
1 FORM 4 wk-form4_1773695160.xml 4 9813
  Complete submission text file 0001922964-26-000006.txt   11215
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Muzzey Dale (Reporting) CIK: 0001922964 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 26757792